Ealixir Stock

Ealixir Net Income

The Net Income of Ealixir (EAXR) as of Aug 15, 2026 is 124,000.00 USD. In the previous year, Net Income was -631,000.00 USD — a change of -119.65% (higher).

Net Income

124,000.00USD

YoY

-119.65%

Last updated:

In 2026, Ealixir's profit amounted to 124,000.00 USD, a -119.65% increase from the -631,000.00 USD profit recorded in the previous year.

The Ealixir Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

NET INCOME (k USD)
Date
NET INCOME (k USD)
Jan 1, 2007
-2,120.00 base
Jan 1, 2008
-3,860.00 base
Jan 1, 2009
-14,564.00 base
Jan 1, 2010
-28,865.80 base
Jan 1, 2011
-10,662.60 base
Jan 1, 2012
-307.00 base
Jan 1, 2020
-631.00 base
Jan 1, 2021
124.00 base
YEARNET INCOME (k USD)
2021 124.00
2020 -631.00
2012 -307.00
2011 -10,662.60
2010 -28,865.80
2009 -14,564.00
2008 -3,860.00
2007 -2,120.00
Access this data via the Eulerpool API

Ealixir Revenue

Ealixir Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2007
966,000.00 USD
-989,000.00 USD
-2.12 M USD
Jan 1, 2008
3.15 M USD
-3.54 M USD
-3.86 M USD
Jan 1, 2009
34.34 M USD
-10.79 M USD
-14.56 M USD
Jan 1, 2010
34.06 M USD
-6.71 M USD
-28.87 M USD
Jan 1, 2011
15.79 M USD
-4.74 M USD
-10.66 M USD
Jan 1, 2012
10.75 M USD
-1.48 M USD
-307,000.00 USD
Jan 1, 2020
0.00 USD
-447,000.00 USD
-631,000.00 USD
Jan 1, 2021
3.53 M USD
0.00 USD
124,000.00 USD

Ealixir Margins

Ealixir stock margins

The Ealixir margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Ealixir. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Ealixir.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2007
93.69 %
-102.38 %
-219.46 %
Jan 1, 2008
-27.84 %
-112.43 %
-122.70 %
Jan 1, 2009
-1.92 %
-31.41 %
-42.41 %
Jan 1, 2010
4.59 %
-19.69 %
-84.75 %
Jan 1, 2011
3.37 %
-30.04 %
-67.54 %
Jan 1, 2012
6.81 %
-13.75 %
-2.86 %
Jan 1, 2020
75.64 %
- %
- %
Jan 1, 2021
75.64 %
0.00 %
3.51 %

Ealixir Stock analysis

What does Ealixir do? Ealixir Inc is a biotechnology company founded in 2012 by Dr. Nithin Rajan. Dr. Rajan earned his doctoral degree in biomedical science from the University of Ottawa and has over ten years of experience in the field of biomedical research. Ealixir Inc is an innovative firm specializing in the development of novel therapeutic technologies based on cell and proteomic research. Ealixir's goal is to help patients with serious or chronic illnesses by offering biological solutions that support the body's natural functions. Ealixir has developed the concept of "lifestyle medicine," aiming to develop treatments that not only combat diseases but also influence the patient's lifestyle to help them lead a healthier life. The company follows an integrative approach, combining the use of medications and other therapeutic approaches. Ealixir specializes in ingredients and technologies that have the potential to stimulate and activate the body to promote natural regenerative processes. One of Ealixir's significant products is the Arthritin system, which is used for the treatment of arthritis and pain. Arthritin utilizes a blend of pain relief, inflammation inhibitors, and regeneration promoters to effectively alleviate arthritis pain and reverse the damage caused by the disease to the joints. Ealixir is also a pioneer in the development of nano "in-minutes" technologies, where nanoparticles are used to actively transport active substances to specific target cells, thereby achieving results in minutes rather than hours. Another important product of Ealixir is Collagenix, a beauty product that uses a blend of collagen, vitamins, and minerals to improve skin structure and wrinkle depth. Ealixir also offers products for animal care and medicine. The company has developed a new product for wound care in pets using the Ealixir technology. The solution consists of antibacterial ingredients and promotes the growth of new tissue. Ealixir also focuses on researching dietary supplements that contribute to overall health and well-being. The company pays special attention to proteins, magnesium, and omega-3 fatty acids. The range includes CBD oil and support for restful sleep. Overall, Ealixir has established itself as a leading company in biomedical research and the development of innovative therapies. The company's products are at the forefront of technology and are developed and tested by a great team of researchers and scientists. The brand has experienced rapid growth in recent years and will undoubtedly achieve many successes in the future, benefiting both patients and animal lovers as well as people who value health and wellness. Ealixir is one of the most popular companies on Eulerpool.

Net Income Details

Understanding Ealixir's Profit Margins

The profit margins of Ealixir represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Ealixir's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Ealixir's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Ealixir's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Ealixir’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Ealixir stock

Net Income of Ealixir is 124,000.00 USD in 2026.

Net Income of Ealixir changed from -631,000.00 USD to 124,000.00 USD, representing a -119.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Income Ealixir since 2006 – with annual values, charts, and detailed analysis.

The achievement of a profit is the biggest goal of a company. The profit can be used for distribution or reinvestment. The profit (also called annual surplus or EAT, earnings after taxes) is the positive difference between income and expenses in a period as shown in the income statement. A negative annual surplus is called annual loss. Both performance measures are also combined under the neutral term annual result.

The Net Income is derived from all revenues / sales minus the expenses in the period under review. The following overview clearly shows which positions contribute to the annual surplus and where the differences lie compared to other variants of profit such as EBT, EBIT, and EBITDA.

Net Income's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Income's Ealixir historically and in real time.

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Access this data via the Eulerpool API

Income Statement — Ealixir

All Key Metrics — Ealixir